Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effects of renal sympathetic denervation on the course of congestive heart failure combined with chronic kidney disease: Insight from studies with fawn-hooded hypertensive rats with volume overload induced using aorto-caval fistula

Z. Honetschlagerová, P. Škaroupková, S. Kikerlová, Z. Husková, H. Maxová, V. Melenovský, E. Kompanowska-Jezierska, J. Sadowski, O. Gawrys, P. Kujal, L. Červenka, V. Čertíková Chábová

. 2021 ; 43 (6) : 522-535. [pub] 20210330

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003917

Background: The coincidence of congestive heart failure (CHF) and chronic kidney disease (CKD) results in poor survival rate. The aim of the study was to examine if renal denervation (RDN) would improve the survival rate in CHF induced by creation of aorto-caval fistula (ACF).Methods: Fawn-hooded hypertensive rats (FHH), a genetic model of spontaneous hypertension associated with CKD development, were used. Fawn-hooded low-pressure rats (FHL), without CKD, served as controls. RDN was performed 4 weeks after creation of ACF and the follow-up period was 10 weeks.Results: We found that intact (non-denervated) ACF FHH exhibited survival rate of 58.8% (20 out of 34 rats), significantly lower than in intact ACF FHL (81.3%, 26/32 rats). In intact ACF FHL albuminuria remained stable throughout the study, whereas in ACF FHH it increased significantly, up to a level 40-fold higher than the basal values. ACF FHL did not show increases in renal glomerular and tubulointerstitial injury as compared with FHL, while ACF FHH exhibited marked increases in kidney injury as compared with FHH. RDN did not improve the survival rate in either ACF FHL or ACF FHH and did not alter the course of albuminuria in ACF FHL. RDN attenuated the albuminuria, but did not reduce the kidney injury in ACF FHH.Conclusions: Our present results support the notion that even modest CKD increases CHF-related mortality. RDN did not attenuate CHF-dependent mortality in ACF FHH, it delayed the progressive rise in albuminuria, but it did not reduce the degree of kidney injury.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003917
003      
CZ-PrNML
005      
20220530150550.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/10641963.2021.1907398 $2 doi
035    __
$a (PubMed)33783285
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Honetschlagerová, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Effects of renal sympathetic denervation on the course of congestive heart failure combined with chronic kidney disease: Insight from studies with fawn-hooded hypertensive rats with volume overload induced using aorto-caval fistula / $c Z. Honetschlagerová, P. Škaroupková, S. Kikerlová, Z. Husková, H. Maxová, V. Melenovský, E. Kompanowska-Jezierska, J. Sadowski, O. Gawrys, P. Kujal, L. Červenka, V. Čertíková Chábová
520    9_
$a Background: The coincidence of congestive heart failure (CHF) and chronic kidney disease (CKD) results in poor survival rate. The aim of the study was to examine if renal denervation (RDN) would improve the survival rate in CHF induced by creation of aorto-caval fistula (ACF).Methods: Fawn-hooded hypertensive rats (FHH), a genetic model of spontaneous hypertension associated with CKD development, were used. Fawn-hooded low-pressure rats (FHL), without CKD, served as controls. RDN was performed 4 weeks after creation of ACF and the follow-up period was 10 weeks.Results: We found that intact (non-denervated) ACF FHH exhibited survival rate of 58.8% (20 out of 34 rats), significantly lower than in intact ACF FHL (81.3%, 26/32 rats). In intact ACF FHL albuminuria remained stable throughout the study, whereas in ACF FHH it increased significantly, up to a level 40-fold higher than the basal values. ACF FHL did not show increases in renal glomerular and tubulointerstitial injury as compared with FHL, while ACF FHH exhibited marked increases in kidney injury as compared with FHH. RDN did not improve the survival rate in either ACF FHL or ACF FHH and did not alter the course of albuminuria in ACF FHL. RDN attenuated the albuminuria, but did not reduce the kidney injury in ACF FHH.Conclusions: Our present results support the notion that even modest CKD increases CHF-related mortality. RDN did not attenuate CHF-dependent mortality in ACF FHH, it delayed the progressive rise in albuminuria, but it did not reduce the degree of kidney injury.
650    _2
$a zvířata $7 D000818
650    12
$a píštěle $7 D005402
650    12
$a srdeční selhání $x etiologie $7 D006333
650    12
$a hypertenze $x komplikace $7 D006973
650    _2
$a ledviny $7 D007668
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a chronická renální insuficience $x komplikace $7 D051436
650    _2
$a sympatektomie $7 D013562
655    _2
$a časopisecké články $7 D016428
700    1_
$a Škaroupková, Petra $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kikerlová, Soňa $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Husková, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Maxová, Hana $u Department of Pathophysiology, Medicine, Charles University, Prague, Czech Republic
700    1_
$a Melenovský, Vojtěch $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kompanowska-Jezierska, Elżbieta, $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Institute, Polish Academy of Science, Warsaw, Poland $d 1959- $7 xx0273376
700    1_
$a Sadowski, Janusz $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Institute, Polish Academy of Science, Warsaw, Poland
700    1_
$a Gawrys, Olga $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Institute, Polish Academy of Science, Warsaw, Poland
700    1_
$a Kujal, Petr $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Pathology, Medicine, Charles University, Prague, Czech Republic
700    1_
$a Červenka, Luděk $u Department of Pathophysiology, Medicine, Charles University, Prague, Czech Republic
700    1_
$a Čertíková Chábová, Věra $u Department of Nephrology, Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00005536 $t Clinical and experimental hypertension (New York, N.Y. : 1993) $x 1525-6006 $g Roč. 43, č. 6 (2021), s. 522-535
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33783285 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220530150548 $b ABA008
999    __
$a ok $b bmc $g 1751394 $s 1155066
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 43 $c 6 $d 522-535 $e 20210330 $i 1525-6006 $m Clinical and experimental hypertension $n Clin Exp Hypertens $x MED00005536
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...